NCT03488706View on ClinicalTrials.gov

Assessing Circulating Tumor Cell as a Biomarker for Prostate Cancer Detection in Patients With Gray Zone PSA Level

UnknownOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

January 17, 2018

Primary Completion Date

December 12, 2018

Study Completion Date

June 2, 2021

Conditions
Prostate Cancer
Trial Locations (1)

Unknown

RECRUITING

Linkou Chang Gung Memorial Hospital, Taoyuan

Sponsors

Lead Sponsor

CellMaxLife
All Listed Sponsors
lead

CellMaxLife

INDUSTRY